Literature DB >> 16238547

Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

Derek N Lavery1, Iain J McEwan.   

Abstract

Steroid hormones are important endocrine signalling molecules controlling reproduction, development, metabolism, salt balance and specialized cellular responses, such as inflammation and immunity. They are lipophilic in character and act by binding to intracellular receptor proteins. These receptors function as ligand-activated transcription factors, switching on or off networks of genes in response to a specific hormone signal. The receptor proteins have a conserved domain organization, comprising a C-terminal LBD (ligand-binding domain), a hinge region, a central DBD (DNA-binding domain) and a highly variable NTD (N-terminal domain). The NTD is structurally flexible and contains surfaces for both activation and repression of gene transcription, and the strength of the transactivation response has been correlated with protein length. Recent evidence supports a structural and functional model for the NTD that involves induced folding, possibly involving alpha-helix structure, in response to protein-protein interactions and structure-stabilizing solutes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16238547      PMCID: PMC1276946          DOI: 10.1042/BJ20050872

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  175 in total

Review 1.  NPS@: network protein sequence analysis.

Authors:  C Combet; C Blanchet; C Geourjon; G Deléage
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  The N-terminal region of the human progesterone A-receptor. Structural analysis and the influence of the DNA binding domain.

Authors:  D L Bain; M A Franden; J L McManaman; G S Takimoto; K B Horwitz
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  Architectural principles for the structure and function of the glucocorticoid receptor tau 1 core activation domain.

Authors:  A Wärnmark; J A Gustafsson; A P Wright
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

4.  p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.

Authors:  Y Kobayashi; T Kitamoto; Y Masuhiro; M Watanabe; T Kase; D Metzger; J Yanagisawa; S Kato
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

5.  From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator.

Authors:  D K Lee; H O Duan; C Chang
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

6.  Mutation of the androgen receptor causes oncogenic transformation of the prostate.

Authors:  Guangzhou Han; Grant Buchanan; Michael Ittmann; Jonathan M Harris; Xiaoqing Yu; Francesco J Demayo; Wayne Tilley; Norman M Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-18       Impact factor: 11.205

7.  Hey1, a mediator of notch signaling, is an androgen receptor corepressor.

Authors:  Borja Belandia; Sue M Powell; Juana M García-Pedrero; Marjorie M Walker; Charlotte L Bevan; Malcolm G Parker
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

8.  The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists.

Authors:  Myles C Hodgson; Inna Astapova; Shinta Cheng; Larissa J Lee; Manon C Verhoeven; Eunis Choi; Steven P Balk; Anthony N Hollenberg
Journal:  J Biol Chem       Date:  2004-12-14       Impact factor: 5.157

9.  FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors.

Authors:  Tomoshige Kino; Takamasa Ichijo; George P Chrousos
Journal:  J Steroid Biochem Mol Biol       Date:  2004-12-19       Impact factor: 4.292

10.  Negative modulation of androgen receptor transcriptional activity by Daxx.

Authors:  Ding-Yen Lin; Hsin-I Fang; Ai-Hong Ma; Yen-Sung Huang; Yeong-Shiau Pu; Guido Jenster; Hsing-Jien Kung; Hsiu-Ming Shih
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more
  61 in total

1.  Thermodynamic dissection of the intrinsically disordered N-terminal domain of human glucocorticoid receptor.

Authors:  Jing Li; Hesam N Motlagh; Carolyn Chakuroff; E Brad Thompson; Vincent J Hilser
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

Review 2.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

3.  Conservation of progesterone hormone function in invertebrate reproduction.

Authors:  E Paige Stout; James J La Clair; Terry W Snell; Tonya L Shearer; Julia Kubanek
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

4.  Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.

Authors:  Prashant Rajbhandari; Greg Finn; Natalia M Solodin; Kiran K Singarapu; Sarata C Sahu; John L Markley; Kelley J Kadunc; Stephanie J Ellison-Zelski; Anastasia Kariagina; Sandra Z Haslam; Kun Ping Lu; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

5.  Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease.

Authors:  Zhao-Xia Yang; Wei Shen; Hang Sun
Journal:  Hepatol Int       Date:  2010-08-12       Impact factor: 6.047

6.  Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.

Authors:  Hany Abdel-Hafiz; Michelle L Dudevoir; Kathryn B Horwitz
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

Review 7.  Allosteric pathways in nuclear receptors - Potential targets for drug design.

Authors:  Elias J Fernandez
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

8.  Proteasomal degradation unleashes the pro-death activity of androgen receptor.

Authors:  Bradley Godfrey; Yuting Lin; Jeffery Larson; Bonnie Haferkamp; Jialing Xiang
Journal:  Cell Res       Date:  2010-05-18       Impact factor: 25.617

Review 9.  Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain.

Authors:  N G R Dayan Elshan; Matthew B Rettig; Michael E Jung
Journal:  Med Res Rev       Date:  2018-11-22       Impact factor: 12.944

10.  Disordered allostery: lessons from glucocorticoid receptor.

Authors:  Hesam N Motlagh; Jeremy A Anderson; Jing Li; Vincent J Hilser
Journal:  Biophys Rev       Date:  2015-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.